Investment funds have developed an interest in trading capital for royalties on drug commercializations
John Tamisiea, McDermott, Will & Emery
Advertisement
Articles by John Tamisiea, McDermott, Will & Emery
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
What DOL’s Final PBM Rule Means for Rebates and Formularies
2
Large Pharma vs. Emerging Biotech: Two Launch Playbooks
3
Pharma Pulse: GoodRx Opens Employer GLP-1 Channel, Lilly Fends Off Novo Ad Challenge, PCMA Takes Aim at Wholesalers
4
FAQ: How DOL’s PBM Disclosure Rule Reaches Drugmaker Contracts
5